148 results
6-K
EX-99.1
BLU
Bellus Health Inc
16 Jun 23
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
4:21pm
are by their nature subject to a number of factors that could cause actual results to differ materially from management’s expectations and plans as set forth
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
of the Company or any optionee, for any purpose whatsoever, including, without limitation for the purpose of:
amendments of a “housekeeping” nature, which … a comprehensive orientation. All new directors should understand the nature and operation of the issuer’s business.
The board should provide continuing education
6-K
EX-99.3
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
unclaimed, in each case, on or before the sixth anniversary of the Effective Time shall cease to represent a right or claim of any kind or nature.
- 2 … the sixth anniversary of the Effective Date shall cease to represent a claim by or interest of any former holder of Shares of any kind or nature against
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
conditions for a transaction of this nature, including court approval, approval of Shareholders in the manner described above and applicable regulatory … statements are by their nature subject to a number of factors that could cause actual results to differ materially from management’s expectations and plans
6-K
EX-99.1
BLU
Bellus Health Inc
16 May 23
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
5:04pm
effect, these forward-looking statements are by their nature subject to a number of factors that could cause actual results to differ materially from
6-K
EX-99.1
mll756p tmr
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
6-K
EX-99.2
s9ycw
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
6-K
EX-99.2
7vga1l0u8f7x20d
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.3
n4vs0z lq49hq7
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.2
orh4qezpl9vybu9
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
nwemvq1w
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.1
ykht tpusy8qdyv
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
6-K
EX-99.2
4rphc grltfqyv
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
4t3ow14rs4z2578ryiw
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
im6 wc5rm
16 Sep 22
Investor Presentation NASDAQ/TSX - BLU September 16 th , 2022
4:40pm
F-10
s0rtu
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.1
g3m2g77
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.2
95iiwo
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
SUPPL
sn22wlhnuduopvll
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
yptt qc93en3
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm